Skip to main content
. Author manuscript; available in PMC: 2010 Jan 1.
Published in final edited form as: Ageing Res Rev. 2008 Oct 31;8(1):43–51. doi: 10.1016/j.arr.2008.10.002

Table 1.

Comparison of phenotypes between klotho deficient and klotho overexpression mice

Parameters Klotho deficient mice Klotho overexpression mice
Body weight Showing growth retardation and becoming inactive and marantic at 3 to 4 weeks of age (Kuro-o et al., 1997). Normal (Kurosu et al., 2005)
Average lifespan About 2 months (vs 2.5 to 3 years for wild-type mice) (Kuro-o et al., 1997). About 20–30% longer than wild-type mice (Kurosu et al., 2005).
Maximal lifespan Less than 100 days (Kuro-o et al., 1997). More than 936 days (Kurosu et al., 2005).
Insulin Decreased insulin secretion and enhanced insulin sensitivity (Kuro-o et al., 1997). Increased resistance to insulin and IGF-1 signaling (Kurosu et al., 2005).
Phosphorus homeostasis Hyperphosphatemia (Kuro-o et al., 1997). Normal (Kurosu et al., 2005).
Calcium homeostasis Ectopic calcification in various organs (Kuro-o et al., 1997). Normal (Kurosu et al., 2005).
Diseases Hypogonadism, infertility, premature thymic involution, ectopic calcification, decreased bone mineral density, skin and muscle atrophy, ataxia, emphysema, cognitive impairment, hearing loss, vascular calcification (Kuro-o et al., 1997). Reduction of NO synthesis in vascular endothelial cells (Saito et al., 1998). Protection of the angiotensin II-induced renal damage (Mitani et al., 2002).
Suppression of H2O2-induced apoptosis and cellular senescence in vascular cells (Ikushima et al., and 2006). Reduction of risk factors for atherosclerosis. Enhanced hearing ability (Bektas et al., 2004)